The Shapewear market is projected to reach US$ 5.7 Bn by 2030. And registering a CAGR of around 11.0% over the forecast period 2021 – 2030.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38469
Growth Factors
The growth of this market is fueled by factors such as changing lifestyles, increased use of compression wear among the geriatric population, and developments in garment designs and fabric technology. Furthermore, the rise in online sales of compression wear and shapewear, as well as the rising demand for plus-size clothes, has fueled the growth of the market.
The market is also influenced by a variety of cultural factors. When it comes to the body, the concept of perfection is being replaced with the concept of self-love and comfort in one’s own shape and size. The market has been influenced by this body-positivity philosophy.
Report Highlights
The female segment dominated the market and accounted for the largest revenue share of 104.0% in 2020. The segment is primarily driven by advancements in shapewear fabrics and an increase in product launches for females. Different types of shapewear have been introduced in the market for women, such as bodysuits, girdles, corsets, control panties, control tights, control slips, slimming camisoles, and brassieres, which is the key factor driving this segment. New product innovations concerning different body areas such as tummy, butt, and thighs are favoring the sales of the companies operating in this segment.
The specialty stores segment dominated the market and accounted for the largest revenue share of 68.4% in 2020. An increasing number of apparel retail outlets, especially in emerging countries like India, China, and Brazil is expected to have a positive impact on market growth.
The online segment is anticipated to witness significant CAGR over the forecast period. The rise of the online segment can be ascribed to technical improvements and the increasing importance given to online platforms for purchasing surfing apparel and accessories, particularly by consumers looking for bargains. The main target demographic for online platforms is customers who are comfortable purchasing things without physically inspecting them.
North America dominated the shapewear market and accounted for the largest revenue share of 48.8% in 2020. This is due to the widespread popularity of athletics and sports, as well as the presence of a large number of sophisticated consumers. The most popular compression wear items include bottoms, shirts, sleeves, and socks, while waist cinchers, bodysuits, and briefs are popular shapewear items in the United States.
Key Players
- Nike, Inc.
- Adidas AG
- Spanx Inc.
- Triumph International Corporation
- Leonisa
- Wacoal America, Inc.
- Ann Chery
- 2XU Pty. Ltd.
- Under Armour Inc.
- Skins International Trading AG
| Report Coverage | Details |
| Market Size | US$ 5.7 billion by 2030 |
| Growth Rate | CAGR of 11.0% From 2021 to 2030 |
| Base Year | 2020 |
| Historic Data | 2017 to 2020 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | End-user, Distribution Channel |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | Nike, Inc.; Adidas AG; Spanx Inc.; Triumph International Corporation; Leonisa; Wacoal America, Inc; Ann Chery; 2XU Pty. Ltd.; Under Armour Inc; Skins International Trading AG |
Market Segmentation
- End-user
- Male
- Female
- Distribution Channel
- Hypermarkets & Supermarkets
- Specialty Stores
- Online
- Others
- Region
- North America
- U.S.
- Europe
- U.K.
- Germany
- Asia Pacific
- China
- India
- Central & South America
- Brazil
- Middle East & Africa
- North America
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38469
Reasons to Purchase this Report:
– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Shapewear Market, By Biopsy End-user
7.1. Shapewear Market, by Biopsy End-user, 2021-2030
7.1.1. Male
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Female
7.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Shapewear Market, By Distribution Channel
8.1. Shapewear Market, by Distribution Channel, 2021-2030
8.1.1. Hypermarkets & Supermarkets
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Specialty Stores
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Online
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Others
8.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Shapewear Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Biopsy End-user (2017-2030)
9.1.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Biopsy End-user (2017-2030)
9.1.3.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Biopsy End-user (2017-2030)
9.1.4.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Biopsy End-user (2017-2030)
9.2.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Biopsy End-user (2017-2030)
9.2.3.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Biopsy End-user (2017-2030)
9.2.4.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Biopsy End-user (2017-2030)
9.2.5.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Biopsy End-user (2017-2030)
9.2.6.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Biopsy End-user (2017-2030)
9.3.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Biopsy End-user (2017-2030)
9.3.3.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Biopsy End-user (2017-2030)
9.3.4.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Biopsy End-user (2017-2030)
9.3.5.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Biopsy End-user (2017-2030)
9.3.6.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Biopsy End-user (2017-2030)
9.4.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Biopsy End-user (2017-2030)
9.4.3.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Biopsy End-user (2017-2030)
9.4.4.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Biopsy End-user (2017-2030)
9.4.5.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Biopsy End-user (2017-2030)
9.4.6.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Biopsy End-user (2017-2030)
9.5.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Biopsy End-user (2017-2030)
9.5.3.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Biopsy End-user (2017-2030)
9.5.4.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)
Chapter 10. Company Profiles
10.1. Nike, Inc.
10.1.1. Company Overview
10.1.2. Biopsy End-user Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Adidas AG
10.2.1. Company Overview
10.2.2. Biopsy End-user Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Spanx Inc.
10.3.1. Company Overview
10.3.2. Biopsy End-user Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Triumph International Corporation
10.4.1. Company Overview
10.4.2. Biopsy End-user Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Leonisa
10.5.1. Company Overview
10.5.2. Biopsy End-user Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Wacoal America, Inc.
10.6.1. Company Overview
10.6.2. Biopsy End-user Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Ann Chery
10.7.1. Company Overview
10.7.2. Biopsy End-user Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. 2XU Pty. Ltd.
10.8.1. Company Overview
10.8.2. Biopsy End-user Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Under Armour Inc.
10.9.1. Company Overview
10.9.2. Biopsy End-user Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Skins International Trading AG
10.10.1. Company Overview
10.10.2. Biopsy End-user Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38469
Contact Us:
Vision Research Reports
Call: +1 9197 992 333
